Trial intelligence / Profile preview

Thiamine in Septic Shock

NCT01070810Phase 2Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Feb 2010
Primary completion
Nov 2014
Countries
1
01

Overview

A Phase 2 trial of thiamine in septic shock, sponsored by Beth Israel Deaconess Medical Center. Started Feb 2010; status: completed.

02

Drugs

thiamine
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT01070810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01070810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call